Canada markets closed

BriaCell Therapeutics Corp. (BCT.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
1.3500+0.0600 (+4.65%)
At close: 03:39PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 48.38M
Enterprise Value 47.11M
Trailing P/E 730.70
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)16.97
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.83
52-Week Change 3-82.14%
S&P500 52-Week Change 332.65%
52 Week High 38.0000
52 Week Low 30.6400
50-Day Moving Average 30.9597
200-Day Moving Average 32.9271

Share Statistics

Avg Vol (3 month) 344.77k
Avg Vol (10 day) 3129.48k
Shares Outstanding 535.84M
Implied Shares Outstanding 635.84M
Float 815.09M
% Held by Insiders 19.26%
% Held by Institutions 115.02%
Shares Short (Sept 13, 2024) 41.89k
Short Ratio (Sept 13, 2024) 40.07
Short % of Float (Sept 13, 2024) 40.01%
Short % of Shares Outstanding (Sept 13, 2024) 40.01%
Shares Short (prior month Aug 15, 2024) 41.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 02, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21009:1000
Last Split Date 3Sept 05, 2023

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Jul 31, 2023
Most Recent Quarter (mrq)Apr 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-122.71%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -35.25M
Net Income Avi to Common (ttm)-6M
Diluted EPS (ttm)-0.5000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)935.69k
Total Cash Per Share (mrq)0.05
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.82
Book Value Per Share (mrq)-0.37

Cash Flow Statement

Operating Cash Flow (ttm)-31.01M
Levered Free Cash Flow (ttm)-17.95M